Palatin Technologies News

Buy Rating Endorsed for Palatin Technologies Amidst Promising Obesity Treatment Advancements

TipRanks49minutes ago

Buy Rating Affirmed for Palatin Technologies Following Successful Phase 3 Trial of PL9643 for Dry Eye Disease

TipRanksApr 8 23:05

Maintained Buy Rating on Palatin Technologies Amid Promising Clinical Results and Future Prospects

TipRanksFeb 29 20:56

Analysts Offer Insights on Healthcare Companies: Palatin Technologies (PTN) and Opko Health (OPK)

TipRanksFeb 28 23:10

Buy Rating Affirmed on Palatin Technologies for Promising Pipeline and Strategic Market Positioning

TipRanksFeb 16 20:36

HC Wainwright & Co. Reiterates Buy on Palatin Techs, Maintains $70 Price Target

BenzingaFeb 16 01:39

Palatin Techs Analyst Ratings

BenzingaFeb 16 01:37

Optimistic Buy Rating for Palatin Technologies Backed by Strong Clinical Pipeline and Strategic Initiatives

TipRanksFeb 16 00:45

Optimistic Outlook for Palatin Technologies: A Comprehensive Buy Rating Based on Strong Clinical Pipeline and Upcoming Milestones

TipRanksJan 9 19:35

Analysts Offer Insights on Healthcare Companies: Liquidia Technologies (LQDA), Henry Schein (HSIC) and Palatin Technologies (PTN)

TipRanksDec 21, 2023 19:50

Analysts Are Bullish on Top Healthcare Stocks: Bioventus (BVS), Palatin Technologies (PTN)

TipRanksDec 20, 2023 21:40

Analysts Offer Insights on Healthcare Companies: Illumina (ILMN), Palatin Technologies (PTN) and Medtronic (MDT)

TipRanksDec 18, 2023 20:50

Analysts Offer Insights on Healthcare Companies: Urogen Pharma (URGN), Palatin Technologies (PTN) and ProKidney (PROK)

TipRanksNov 15, 2023 20:31

Palatin Technologies Receives Buy Rating: F1Q24 Results Surpass Expectations and MELODY-1 Trial Shows Promising Progress

TipRanksNov 15, 2023 00:15

Promising Preclinical Data Bolsters Buy Rating for Palatin Technologies: PL8177's Potential in Ulcerative Colitis Treatment

TipRanksOct 16, 2023 22:25

Buy Rating for Palatin Technologies: Promising Clinical Programs and High Upside Potential

TipRanksSep 29, 2023 19:26

Palatin Technologies Earns Buy Rating Amid Strong Performance and Promising Clinical Developments

TipRanksSep 28, 2023 22:47

H.C. Wainwright Sticks to Their Buy Rating for Palatin Technologies (PTN)

TipRanksSep 7, 2023 22:15

Palatin Techs Analyst Ratings

BenzingaAug 10, 2023 20:04

HC Wainwright & Co. Reiterates Buy on Palatin Techs, Maintains $70 Price Target

BenzingaAug 9, 2023 00:26